62 results
8-K
EX-10.1
ENTA
Enanta Pharmaceuticals Inc
12 Mar 24
Departure of Directors or Certain Officers
4:00pm
Event (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares
S-3
EX-4.3
ENTA
Enanta Pharmaceuticals Inc
22 Nov 23
Shelf registration
4:38pm
has been obtained by the Trustee as hereinafter in this Article provided, the Holders of a majority in principal amount of the outstanding Securities … period by the Holders of a majority in principal amount of the outstanding Securities of that Series;
it being understood, intended and expressly
S-3
ENTA
Enanta Pharmaceuticals Inc
22 Nov 23
Shelf registration
4:38pm
of the company, or a merger, a sale of shares representing majority voting power, or a sale of substantially all the assets of the company, referred … and nonassessable. With the approval of a majority of the outstanding shares of the Series 1 Nonconvertible Preferred Stock, we may call for redemption shares
8-K
EX-99.1
ocuy7ca a1dmzito6
7 Jun 23
Regulation FD Disclosure
7:01am
8-K
EX-10.1
21xjj
27 Apr 23
Non-Dilutive and Strengthens Balance Sheet
4:43pm
424B5
iq3u3lba
26 Aug 22
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.1
9fi8rd
8 Aug 22
Results of Operations and Financial Condition
4:04pm
8-K
EX-10.1
2psxsxuifnj9
8 Mar 22
Submission of Matters to a Vote of Security Holders
4:00pm
S-3ASR
5fgs90c3phru5jjdeqn
9 Aug 21
Automatic shelf registration
4:11pm
S-3ASR
EX-4.3
22ndemhg oqpw1rouw
9 Aug 21
Automatic shelf registration
4:11pm